drugset / Trial / NCT00439244
Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the effects of zoledronic acid administered at the same time with teriparatide compared to zoledronic acid alone and teriparatide alone on bone mineral density (BMD) gain in the lumbar spine and total hip
Timeline
- Start
- 2006-12
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |
| Subject | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |